ColiseoHead-to-Head Startup Ranking & Discovery
E
Eugit Therapeutics targets the issue of non-specific drugs that cause toxicity and clinical trial failures, affecting millions with tissue-specific inflammatory diseases. TAGHOME delivers drugs with precision to diseased tissues using T cell receptors, enhancing safety and improving efficacy. Our initial focus is on the 3.1 million U.S. individuals with Inflammatory Bowel Disease, aiming to initiate clinical trials within two years. Cofounded by George Church (Harvard) and funded by Y Combinator (S22).
Founded
2022
Headquarters
San Francisco, CA, USA; South San Francisco, CA, USA
Team size
1–10
Stage
Early-stage
📊 Coliseo ratings
🏆 Overall 1483 Elo
Total matchups0
⚔️ Vote on today's matchups →Ratings are live Elo scores from head-to-head crowd votes — opinion, not fact or financial advice. How it works →